1-20 of 2827
Sort by
Journal Article
Changrong Nie and others
European Heart Journal - Quality of Care and Clinical Outcomes, Volume 11, Issue 3, April 2025, Pages 271–281, https://doi.org/10.1093/ehjqcco/qcae101
Published: 01 May 2025
Image
Published: 01 May 2025
Figure 1 The prevalence of PACs, PACs >100 beats/day, PACs >200 beats/day, SVT, ESVEA1, and ESVEA3 in patients with obstructive hypertrophic cardiomyopathy.
Image
Published: 01 May 2025
Figure 3 Incidence of new-onset atrial fibrillation per 1000 patient-years in relation to the burden of PACs ( A ) and length of short runs of PACs ( C ); Incidence of composite endpoint per 1000 patient-years in relation to the burden of PACs ( B ) and length of short runs of PACs ( D ). * means significant
Journal Article
Andrea Attanasio and others
European Heart Journal - Quality of Care and Clinical Outcomes, Volume 11, Issue 3, April 2025, Pages 223–224, https://doi.org/10.1093/ehjqcco/qcaf015
Published: 01 May 2025
Image
Published: 01 May 2025
Graphical Abstract Graphical Abstract
Image
Published: 01 May 2025
Figure 5 Kaplan–Meier survival estimate of composite endpoint events stratified by tertiles ( A ), SVT ( B ), PACs >100 beats/day ( C ), PACs >200 beats/day ( D ), ESVEA1 ( E ), and ESVEA3 ( F ).
Image
Published: 01 May 2025
Figure 2 ( A ) Results of multivariable logistic regression analysis for postoperative atrial fibrillation. ( B ) Results of multivariable Cox regression analysis for new-onset atrial fibrillation. ( C ) Results of multivariable Cox regression analysis for composite endpoints.
Image
Published: 01 May 2025
Figure 4 Kaplan–Meier survival estimate of new-onset atrial fibrillation stratified by tertiles ( A ), SVT ( B ), PACs >100 beats/day ( C ), PACs > 200beats/day ( D ), ESVEA1 ( E ), and ESVEA3 ( F ).
Image
Published: 29 April 2025
Graphical abstract Graphical abstract
Journal Article
ACCEPTED MANUSCRIPT
Eva Steinacher and others
European Heart Journal - Quality of Care and Clinical Outcomes, qcaf023, https://doi.org/10.1093/ehjqcco/qcaf023
Published: 29 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Alberto Cordero and Mª Amparo Quintanilla
European Heart Journal - Quality of Care and Clinical Outcomes, qcaf025, https://doi.org/10.1093/ehjqcco/qcaf025
Published: 29 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Kiarash Tavakoli and others
European Heart Journal - Quality of Care and Clinical Outcomes, qcaf022, https://doi.org/10.1093/ehjqcco/qcaf022
Published: 22 April 2025
Image
Published: 22 April 2025
Graphical Abstract Graphical Abstract
Image
Published: 17 April 2025
Figure 2 Kaplan–Meier curves for the time to first uptitration, stratified by statin intensity at initiation. HR, hazard ratio; adjusted for age, SES, CVD history, diabetes, LDL-c levels, smoking status, BMI, year of initiation, statin intensity at initiation, use of blood pressure-lowering drugs, use of ant
Image
Published: 17 April 2025
Figure 3 Women-to-men hazard ratios of statin uptitration—stratified by statin intensity at initiation and age category. The analyses were adjusted for age, SES, CVD history, diabetes, LDL-c levels, smoking status, BMI, year of initiation, statin intensity at initiation, use of blood pressure-lowering drugs,
Image
Published: 17 April 2025
Figure 4 Women-to-men hazard ratios of statin uptitration among individuals without LDL-c achievement at 6 months—stratified by statin intensity at initiation and age category. The main analyses were adjusted for age, SES, CVD history, diabetes, LDL-c levels, smoking status, BMI, year of initiation, statin i
Journal Article
Pauline Kiss and others
European Heart Journal - Quality of Care and Clinical Outcomes, qcaf017, https://doi.org/10.1093/ehjqcco/qcaf017
Published: 17 April 2025
Image
Published: 17 April 2025
Graphical Abstract Graphical Abstract
Image
Published: 17 April 2025
Figure 1 Kaplan meier curves for the time to first uptitration. HR, hazard ratio; adjusted for age, SES, CVD history, diabetes, LDL-c levels, smoking status, BMI, year of initiation, statin intensity at initiation, use of blood pressure-lowering drugs, use of antiplatelets, and family history of IHD.
Image
Published: 17 April 2025
Figure 5 Women-to-men risk ratios for the achievement of LDL-c target levels. The main analyses were adjusted for age, SES, CVD history, diabetes, LDL-c levels, smoking status, BMI, year of initiation, statin intensity at initiation, use of blood pressure-lowering drugs, use of antiplatelets, and family hist